Literature DB >> 20427160

Doxorubicin-incorporated nanoparticles composed of poly(ethylene glycol)-grafted carboxymethyl chitosan and antitumor activity against glioma cells in vitro.

Young-Il Jeong1, Shu-Guang Jin, In-Young Kim, Jian Pei, Min Wen, Tae-Young Jung, Kyung-Sub Moon, Shin Jung.   

Abstract

In this study, methoxy poly(ethylene glycol)-grafted carboxymethyl chitosan (CMCPEG) was synthesized to make nanoparticles with doxorubicin (DOX) by ion complex formation. Since DOX has positive amine groups, it can interact with the carboxymethyl group of CMCPEG. The particle size of DOX-incorporated nanoparticles of CMCPEG was < 300 nm and nanoparticles had spherical shapes at morphological observation, indicating that DOX/CMCPEG mixtures can form spherical nanoparticles. In a drug release study, higher drug content induced an extended release of drug. Drug release was significantly changed by the release media pH. DOX release was faster at an acidic pH than a neutral or basic pH. The antitumor activity of DOX-incorporated nanoparticles in vitro was tested with DOX-resistant C6 glioma cells. Nanoparticles showed increased cytotoxicity compared to DOX alone. These results suggest that DOX was unable to penetrate into cells and did not effectively inhibit cell proliferation. In contrast, nanoparticles can penetrate into cells and effectively inhibit cell proliferation. Observation of cells under red fluorescence confirmed these results, i.e., nanoparticle-treated C6 cells, unlike DOX-treated cells, had strong red fluorescence. Since DOX has strong red fluorescence, DOX-incorporated nanoparticles entered into the tumor cells more than DOX alone. As a result, we suggest that DOX-incorporated nanoparticles of CMCPEG are superior candidates for antitumor drug delivery. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20427160     DOI: 10.1016/j.colsurfb.2010.03.037

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  18 in total

1.  Effects of molecular weights on the absorption, distribution and urinary excretion of intraperitoneally administrated carboxymethyl chitosan in rats.

Authors:  Wen Dong; Baoqin Han; Kai Shao; Zhao Yang; Yanfei Peng; Yan Yang; Wanshun Liu
Journal:  J Mater Sci Mater Med       Date:  2012-08-14       Impact factor: 3.896

2.  Comparative effects of controlled release of sodium bicarbonate and doxorubicin on osteoblast and osteosarcoma cell viability.

Authors:  Dishary Banerjee; Susmita Bose
Journal:  Mater Today Chem       Date:  2019-03-04

3.  Regulation of KEAP1 expression by promoter methylation in malignant gliomas and association with patient's outcome.

Authors:  Lucia Anna Muscarella; Raffaela Barbano; Vincenzo D'Angelo; Massimiliano Copetti; Michelina Coco; Teresa Balsamo; Annamaria la Torre; Angelo Notarangelo; Michele Troiano; Salvatore Parisi; Nadia Icolaro; Domenico Catapano; Vanna Maria Valori; Fabio Pellegrini; Giuseppe Merla; Massimo Carella; Vito Michele Fazio; Paola Parrella
Journal:  Epigenetics       Date:  2011-03-01       Impact factor: 4.528

Review 4.  Recent advances of chitosan nanoparticles as drug carriers.

Authors:  Jun Jie Wang; Zhao Wu Zeng; Ren Zhong Xiao; Tian Xie; Guang Lin Zhou; Xiao Ri Zhan; Shu Ling Wang
Journal:  Int J Nanomedicine       Date:  2011-04-11

5.  Doxorubicin-incorporated polymeric micelles composed of dextran-b-poly(DL-lactide-co-glycolide) copolymer.

Authors:  Young-Il Jeong; Do Hyung Kim; Chung-Wook Chung; Jin-Ju Yoo; Kyung Ha Choi; Cy Hyun Kim; Seung Hee Ha; Dae Hwan Kang
Journal:  Int J Nanomedicine       Date:  2011-07-06

6.  Hair dye-incorporated poly-γ-glutamic acid/glycol chitosan nanoparticles based on ion-complex formation.

Authors:  Hye-Young Lee; Young-Il Jeong; Ki-Choon Choi
Journal:  Int J Nanomedicine       Date:  2011-11-17

7.  Ifosfamide-loaded poly (lactic-co-glycolic acid) PLGA-dextran polymeric nanoparticles to improve the antitumor efficacy in Osteosarcoma.

Authors:  Bin Chen; Jie-Zuan Yang; Li-Feng Wang; Yi-Jun Zhang; Xiang-Jin Lin
Journal:  BMC Cancer       Date:  2015-10-21       Impact factor: 4.430

8.  Biocompatibility of chitosan carriers with application in drug delivery.

Authors:  Susana Rodrigues; Marita Dionísio; Carmen Remuñán López; Ana Grenha
Journal:  J Funct Biomater       Date:  2012-09-17

Review 9.  Potential Applications of Chitosan-Based Nanomaterials to Surpass the Gastrointestinal Physiological Obstacles and Enhance the Intestinal Drug Absorption.

Authors:  Nutthapoom Pathomthongtaweechai; Chatchai Muanprasat
Journal:  Pharmaceutics       Date:  2021-06-15       Impact factor: 6.321

10.  Chitosan functionalisation of gold nanoparticles encourages particle uptake and induces cytotoxicity and pro-inflammatory conditions in phagocytic cells, as well as enhancing particle interactions with serum components.

Authors:  Matthew S P Boyles; Theresa Kristl; Ancuela Andosch; Mirjam Zimmermann; Ngoc Tran; Eudald Casals; Martin Himly; Victor Puntes; Christian G Huber; Ursula Lütz-Meindl; Albert Duschl
Journal:  J Nanobiotechnology       Date:  2015-11-18       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.